• SIGN IN
  • GET HELP
  •  

    Home Study Details


    Program Type

    Home Study Webcast

    Credits

    1 Contact Hour(s)

    Release Date

    Tuesday, October 18, 2022

    Offline Date

    Saturday, March 29, 2025

    ACPE Expiration Date

    Monday, September 29, 2025

    Target Audience

    Pharmacist, Pharmacy Technician, Nurse

    Cost

    $4.00

    • Overview

      This course provides a review of the mechanism of the mRNA COVID-19 vaccines and introduces the recently authorized COVID-19 Omicron bivalent booster. The most recent Centers for Disease Control and Prevention recommendations for COVID-19 vaccination are discussed and clinical considerations with the new vaccines explained.

      Handouts

      • Slide Document :   22260H06_2pp.pdf
      • Slide Document :   22260H06_6pp.pdf

      Financial Support By

      PharmCon
    • Pharmacist

      Recognize appropriate recommendations for CDC COVID-19 Omicron bivalent booster recommendations for moderate to severely immunocompromised
      Identify the appropriate Center’s for Disease Control (CDC) COVID-19 vaccine recommendations for the new Omicron Bivalent Pfizer and Moderna booster
      Identify adverse events with the COVID-19 Omicron bivalent booster
      Describe the mechanism of action of the omicron bivalent authorized COVID-19 vaccines

      Pharmacy Technician

      Recognize appropriate recommendations for CDC COVID-19 Omicron bivalent booster recommendations for moderate to severely immunocompromised
      Identify adverse events with the COVID-19 Omicron bivalent booster
      Identify the appropriate Center’s for Disease Control (CDC) COVID-19 vaccine recommendations for the new Omicron Bivalent Pfizer and Moderna booster
      Describe the mechanism of action of the omicron bivalent authorized COVID-19 vaccines

      Nurse

      Describe the mechanism of action of the omicron bivalent authorized COVID-19 vaccines
      Identify the appropriate Center’s for Disease Control (CDC) COVID-19 vaccine recommendations for the new Omicron Bivalent Pfizer and Moderna booster
      Identify adverse events with the COVID-19 Omicron bivalent booster
      Recognize appropriate recommendations for CDC COVID-19 Omicron bivalent booster recommendations for moderate to severely immunocompromised
    • Activity Type

      Knowledge

      CE Broker

      20-956604

      Universal Activity Number

      Pharmacist 0798-0000-22-260-H06-P
      Pharmacy Technician 0798-0000-22-260-H06-T
      Nurse 0798-0000-22-260-H06-N

      ACPE PharmCon is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

      PharmCon is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.

      In order to obtain a Statement of Credit, participants must score no less than a 70% on the activity's test and complete a program evaluation.


    HARDWARE REQUIREMENTS
    Standard Windows/Mac System
    iPad or iPhone
    Minimum screen resolution: 1024x768
    Speakers or headphones
     


    SOFTWARE REQUIREMENTS
    Microsoft Edge
    Internet Explorer 8.0 or higher
    Google Chrome
    Safari
    Firefox 3.0.3 or higher


    NETWORK REQUIREMENTS
    Broadband Internet Connection:
    T1, Hi-speed DSL or Cable
    4G cellular connection
     
     

    This continuing education activity is held as copyright by PharmCon, Inc. Through this notice, PharmCon, Inc. grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).